Ertapenem Sodium Crystalline Form E Preparation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing crystalline forms of ertapenem sodium face challenges such as high solution concentrations leading to degradation, poor purity, and environmental concerns due to excessive solvent use, as well as difficulties in filtration and stability issues.

Innovation Solution

A method involving an aqueous solution of ertapenem sodium at a concentration of 40-100 mg/ml, adjusted to a pH of 5.3-5.6, with incremental additions of methanol and 1-propanol to achieve a specific volume ratio, followed by cooling to precipitate the crystalline form E, which has major X-ray diffraction peaks at specific angles, resulting in high purity and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional concentration and nanofiltration are used to achieve high concentration (above 100 mg/ml) for crystallization, then the crystallization can proceed, but the product undergoes substantive degradation and polymerization, resulting in poor purity and chroma

Engineering Contradiction:
Improveconcentration of ertapenem sodium solutionVSAvoidstability of ertapenem sodium
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the concentration parameter from conventional high concentration (>100 mg/ml) to moderate concentration (40-100 mg/ml), and adjusts the pH parameter to 5.3-5.6, which prevents degradation and polymerization while enabling successful crystallization to obtain high purity product

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces organic solvents (acetone, ethyl acetate, or 1-propanol) as intermediary substances to facilitate crystallization at moderate concentrations without requiring aggressive concentration methods that cause degradation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If large amount of solvent is used in the crystallization process, then the crystallization can proceed, but it is not conducive to environmental protection and increases process complexity

Engineering Contradiction:
Improveamount of solventVSAvoidenvironmental impact
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the solvent volume ratio to 0.5-2 times the aqueous solution volume, significantly reducing solvent consumption compared to conventional methods while maintaining effective crystallization and reducing environmental impact

Inventive Principle:
Principle #35Parameter changes

3Shape

If crystalline form D is prepared using water, methanol, and 1-propanol with cooling, then crystallization occurs, but the particles are small and filtration by suction is difficult

Engineering Contradiction:
Improvecrystal particle sizeVSAvoidfiltration difficulty
Core Design Contradiction:
ShapeVSEase of operation

Solution Approach 1:

The patent adjusts the pH parameter to 5.3-5.6 and uses moderate concentration (40-100 mg/ml) instead of extreme conditions, which promotes formation of larger, more filterable crystals while maintaining crystallization efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary pH adjustment and controlled solvent addition before crystallization, which prepares the system to form crystals of appropriate size and morphology that are easily filterable

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The crystalline form E of ertapenem sodium is stable, easily filtered and dried, with a purity exceeding 98.5%, reducing energy consumption and environmental impact, and facilitating industrial production.

Implementation Method 1

cooling to -10~-5℃ and standing; then adding dropwise methanol and 1-propanol, until the volume ratio of water:methanol:1-propanol is 1:0.8~3:0.8~3.5, and cooling to -30~-10℃ to precipitate crystal

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 2

cooling to -30~-10℃ to precipitate crystal, to obtain the crystalline form E of ertapenem sodium

Methodology Applied
Scientific EffectCrystallisation: Crystallisation

Implementation Method 3

adding dropwise methanol and 1-propanol to the solution obtained in step b), until the volume ratio of water:methanol:1-propanol is 1:0.5~2:0.25~1.5

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentEP2660242B1Crystalline form of ertapenem sodium and preparation method therefor
Publication Date: 2019.06.26 CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO LTD
  • EP2660242B1 patent drawingFigure 1
  • EP2660242B1 patent drawing
  • EP2660242B1 patent drawing

AI summary

Provided is a crystalline form E of ertapenem sodium. Further provided is a method for preparing a crystalline form E of ertapenem sodium, characterized by using an aqueous ertapenem sodium solution at a low concentration as a raw material. The crystalline form E can be easily filtered and dried, the properties in the drying process are stable, and the purity of the crystal is high and can be up to 98.5% or higher.